Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Molecular Profile | STK11 Y253* STK11 dec exp |
Therapy | Sirolimus |
Indication/Tumor Type | stomach carcinoma |
Response Type | predicted - sensitive |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
STK11 Y253* STK11 dec exp | stomach carcinoma | predicted - sensitive | Sirolimus | Preclinical - Cell culture | Actionable | In a preclinical study, Rapamune (sirolimus) suppressed the growth of gastric carcinoma cells harboring STK11 Y253* with decreased Stk11 protein expression in culture (PMID: 32236518). | 32236518 |
PubMed Id | Reference Title | Details |
---|---|---|
(32236518) | Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells. | Full reference... |